View
2
Download
0
Category
Preview:
Citation preview
Prostate: Hormone-sensitive (including
localized) Oral presentations
Dott. Luca Galli
U.O. Oncologia Medica 2 Universitaria
Azienda Ospedaliero-Universitaria Pisana
Pisa
Elegibility
Study schema
Objectives
Patient Baseline Characteristics
Summary of Adverse Events
Leukemia Summary slide
Cause of Death
ITT Disease Free Survival
Overall Survival
>80% vivi a 10 anni
Conclusions
Background
Purpose Moving forward…
To evaluate whether the Decipher genomic classifier determined
from biopsy specimens is prognostic for mets and PCSM in a mixed cohort treated with RP
and RT ± ADT
Patients
Results
High 20%
Int Low
Results
Results
Results
Results
Future perspectives
Conclusions
Too few low risk pts for use in the decision between surveillance vs treatment
Background and hypotheses
Methods
Results
NO HER-2 subtype!
Results
Results
What’s behind all this?
Clinical implications?
**ADT given either adjuvant or early salvage post prostatectomy
* *
Can PAM50 give us something more?
Can PAM50 give us something more?
Future perspectives
Conclusions
Recommended